The DOI matches its Crossref record; 207 of the 207 references it cites were found in a registry or an index.
Sickle Cell Anemia, the First Molecular Disease: Overview of Molecular Etiology, Pathophysiology, and Therapeutic Approaches
Open accessAbstract
The root cause of sickle cell disease is a single β-globin gene mutation coding for the sickle β-hemoglobin chain. Sickle hemoglobin tetramers polymerize when deoxygenated, damaging the sickle erythrocyte. A multifaceted pathophysiology, triggered by erythrocyte injury induced by the sickle hemoglobin polymer, and encompassing more general cellular and tissue damage caused by hypoxia, oxidant damage, inflammation, abnormal intracellular interactions, and reduced nitric oxide bioavailability, sets off the events recognized clinically as sickle cell disease. This disease is a group of related disorders where sickle hemoglobin is the principal hemoglobin species. All have varying degrees of chronic hemolytic anemia, vasculopathy, vasoocclusive disease, acute and chronic organ damage, and shortened life span. Its complex pathophysiology, of which we have a reasonable understanding, provides multiple loci for potential therapeutic intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–207 of 207
In vitro exposure to hydroxyurea reduces sickle red blood cell deformability
Huang, Z., Louderback, J. G., King, S. B., Ballas, S. K., & Kim‐Shapiro, D. B. (2001) · American Journal of Hematology · doi:10.1002/ajh.1098 · Cited by 21
Treating sickle cell pain: An update from the Georgia comprehensive sickle cell center
Platt, A. F., Eckman, J. R., Beasley, J., & Miller, G. (2002) · Journal of Emergency Nursing · doi:10.1067/men.2002.125268 · Cited by 19
Antisickling activity of sodium cromoglicate in sickle-cell disease
Toppet, M., Fall, A. B. K., Ferster, A., Fondu, P., Mélot, C., Vanhaelen‐Fastré, R., & Vanhaelen, M. H. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02508-3 · Cited by 19
Increased erythropoietin level induced by hydroxyurea treatment of sickle cell patients
Papassotiriou, I., Voskaridou, E., Stamoulakatou, A., & Loukopoulos, D. (2000) · The Hematology Journal · doi:10.1038/sj.thj.6200049 · Cited by 18
Ion Content and Transport and the Regulation of Volume in Sickle Cellsa
Brugnara, C., Bunn, H. F., & Tosteson, D. C. (1989) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1989.tb24155.x · Cited by 18
928: Long-Term Oral Phosphodiesterase-5 Inhibitor Therapy Alleviates Recurrent Priapism
Burnett, A. L., Bivalacqua, T. J., Champion, H. C., & Musicki, B. (2006) · The Journal of Urology · doi:10.1016/s0022-5347(18)33164-1 · Cited by 17
Clinical response of patients with sickle cell anemia to cromolyn sodium nasal spray
Karimi, M., Zekavat, O. R., Sharifzadeh, S., & Mousavizadeh, K. (2006) · American Journal of Hematology · doi:10.1002/ajh.20708 · Cited by 16
Cited by
Connolly, B. D., Petry, C., Yadav, S., Demeule, B., Ciaccio, N., Moore, J. M. R., Shire, S. J., & Gokarn, Y. R. (2012) · Biophysical Journal · doi:10.1016/j.bpj.2012.04.047 · Cited by 340
Keller, S. D., Yang, M., Treadwell, M. J., Werner, E. M., & Hassell, K. L. (2014) · Health and Quality of Life Outcomes · doi:10.1186/s12955-014-0125-0 · Cited by 115
“Variations include Hb-SS, Hb-SC and Hb-Sβ [11,12] and individuals with Hb-SS usually, but not always, have more symptoms than those with other genotypes [13-15].”
BackgroundSickle Cell Disease: From Genetics to Curative Approaches
Hardouin, G., Magrin, E., Corsia, A., Cavazzana, M., Miccio, A., & Semeraro, M. (2023) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-120122-081037 · Cited by 40
Alagbe, A. E., Justo Junior, A. S., Ruas, L. P., Tonassé, W. V., Santana, R. M., Batista, T. H. C., Domingos, I. F., Araujo, A. S., Bezerra, M. A. C., Santos, M. N. N., et al. (2018) · Cytokine · doi:10.1016/j.cyto.2017.12.001 · Cited by 20
Metadata
- Authors
- Steinberg, M. H.
- Venue
- The Scientific World JOURNAL
- Publisher
- Hindawi Limited
- Published
- 2008
- Volume
- 8
- Pages
- 1295-1324
- ISSN
- 1537-744X (ISSN-L)
- OpenAlex
- W1992577724
- Cited by
- 293
- References
- 207
- FWCI
- 4.01
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.